R&D
Research & development
From material sourcing to candidate selection, every stage leaves its evidence as data.
Platform
Research platform
Library
Natural product library
Herbal materials are sourced to specification, extracted and fractionated, then maintained as a reproducible screening library.
Screening
Efficacy screening
Active fractions are selected in cell and animal models per disease target, and active constituents are identified step by step.
Data
Knowledge graph · prediction
Constituent–target–disease relationships are structured as a graph so literature evidence and experimental data can be queried together to prioritize candidates.
Pipeline
Pipeline status
| Code | Indication | Discovery | Candidate selection | Preclinical | Clinical | Notes |
|---|---|---|---|---|---|---|
| JRP-101 | Metabolic disease | Efficacy reproducibility secured; preliminary toxicity studies underway | ||||
| JRP-204 | Inflammation · Immunology | Comparing activity across three active fractions | ||||
| JRP-310 | Central nervous system | Target validation and literature-based candidate selection |
* Pipeline entries shown here are placeholder data for layout purposes.